Skip to main content
TipRanks
Go Ultimate75% OFF

Allarity Therapeutics (ALLR) Drug Pipeline

374 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
2X-121 And DovitinibAdvanced Solid TumorsPhase ISuspendedStudy to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid TumorsOct 05, 2022―
Ixabepilone InjectionMetastatic Breast CancerPhase IISuspendedAnti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.Mar 08, 2021―
2X-121Advanced Ovarian CancerPhase IIRecruitingInvestigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian CancerMar 08, 2019―
Irofulven, Prednisolone 10 MgMetastatic Castration-Resistant Prostate Cancer PatientsPhase IICompletedIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Aug 21, 2018―
Parp Inhibitor 2X-121Metastatic Breast CancerPhase IICompletedInvestigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRPApr 26, 2018―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Allarity Therapeutics, Inc. (ALLR) have in its pipeline
Allarity Therapeutics ALLR is currently developing the following drugs: 2X-121 And Dovitinib, Ixabepilone Injection, 2X-121, Irofulven, Prednisolone 10 Mg, Parp Inhibitor 2X-121. These drug candidates are in various stages of clinical development as the company works toward FDA approval.